{"id":"tp-47631","type":"article-newspaper","title":"Genmab Reports Three Phase 3 Wins; Shares Rose 91.5% From Aug. 3 to Nov. 2","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/47631","datePublished":"2026-11-03T12:08:50.000Z","dateModified":"2026-11-03T12:08:50.000Z","language":"en","abstract":"Petosemtamab and Rina-S came through acquisitions, while Genmab is developing epcoritamab with AbbVie.","section":"Business","references":[]}